---
title: Simtra BioPharma Solutions vs WuXi XDC
slug_a: simtra-biopharma-solutions
slug_b: wuxi-xdc
site: cdmo
review_signal_gate: closed
canonical_path: /compare/simtra-biopharma-solutions/wuxi-xdc
---

# Simtra BioPharma Solutions vs WuXi XDC

Side-by-side profile data from each company listing on this directory.

## Simtra BioPharma Solutions

- Profile: [/companies/simtra-biopharma-solutions](/companies/simtra-biopharma-solutions)

Simtra BioPharma Solutions — Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.

Services: 17. Modalities: 5. Indications: 0. Locations: 6. Certifications: 2. The strongest documented coverage currently appears in services (17).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Bioconjugation Services
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Lyophilization (Freeze Drying)
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- HPAPI

## WuXi XDC

- Profile: [/companies/wuxi-xdc](/companies/wuxi-xdc)

WuXi XDC — WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.

Services: 12. Modalities: 2. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Expression: Mammalian